Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -2 | -6 | -4 | -7 | 59 |
| Other Working Capital | 92 | 179 | 68 | 172 | -120 |
| Other Operating Activity | -90 | -195 | -111 | -157 | -197 |
| Operating Cash Flow | $-1 | $-23 | $-47 | $8 | $-259 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 55 | 0 | N/A | N/A |
| Other Financing Activity | 0 | 11 | 0 | -95 | 143 |
| Financing Cash Flow | $0 | $66 | $0 | $-95 | $143 |
| Beginning Cash Position | 67 | 23 | 70 | 157 | 273 |
| End Cash Position | 66 | 67 | 23 | 70 | 157 |
| Net Cash Flow | $-1 | $43 | $-47 | $-87 | $-116 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1 | -23 | -47 | 8 | -259 |
| Free Cash Flow | -1 | -23 | -47 | 8 | -259 |